Back

Recombinant GDF11 Improves Neurological Recovery in Models of Hemorrhagic Stroke and Traumatic Brain Injury

Wang, H.; Cohen, O. S.; Ben Driss, L.; Cantillana, V.; Wang, Y.; Sinha, M.; Deshpande, A.; Daman, T.; Faw, T. D.; Laskowitz, D. T.; Sandrasagra, A.; Lee, R. T.

2026-06-08 neuroscience
10.64898/2026.06.04.730114 bioRxiv
Show abstract

BackgroundIntracerebral hemorrhage (ICH) and traumatic brain injury (TBI) are leading causes of long-term neurological disability and mortality worldwide, with no approved therapies that promote functional recovery. Growth differentiation factor 11 (GDF11), a circulating TGF{beta}-family protein, has shown regenerative and neurorestorative potential in models of ischemic stroke. MethodsWe evaluated recombinant GDF11 (rGDF11) in mouse models of ICH and TBI. ICH was induced by intrastriatal collagenase injection, and neurological recovery was assessed using Neuroseverity Score (NSS), Rotarod (RR), and CatWalk (CW) analyses up to 28 days post-injury. Histological assessments of vascularization, neuronal density, and microglial/macrophage density were performed 28 days after ICH. For TBI, a closed-head injury model using a pneumatic impactor was employed, and NSS and RR assessments were conducted through 28 days post-injury. ResultsrGDF11 treatment significantly improved neurobehavioral performance following ICH, including NSS, RR, and CW parameters (forelimb base of support and average speed). Histological analyses revealed enhanced vascular area and neuronal density, with reduced microglial/macrophage density in rGDF11-treated mice. Following TBI, rGDF11 accelerated functional recovery, improving RR latency by day 6 and NSS by day 28 post-injury. ConclusionrGDF11 promotes structural and functional recovery after both hemorrhagic and traumatic brain injury in mice. These findings, together with prior evidence in ischemic stroke, support rGDF11 as a promising neurorestorative biologic with broad therapeutic potential for diverse forms of brain injury. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=178 SRC="FIGDIR/small/730114v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@8c624forg.highwire.dtl.DTLVardef@8a6107org.highwire.dtl.DTLVardef@e83ce6org.highwire.dtl.DTLVardef@f65f14_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 18%
10.0%
2
Experimental Neurology
61 papers in training set
Top 0.2%
6.4%
3
Stroke
40 papers in training set
Top 0.3%
4.2%
4
Journal of Stroke and Cerebrovascular Diseases
15 papers in training set
Top 0.2%
4.2%
5
Cells
249 papers in training set
Top 0.9%
3.3%
6
Journal of Neuroinflammation
61 papers in training set
Top 0.4%
3.3%
7
Neurocritical Care
12 papers in training set
Top 0.1%
3.3%
8
Frontiers in Neurology
102 papers in training set
Top 1%
3.3%
9
Fluids and Barriers of the CNS
28 papers in training set
Top 0.2%
2.7%
10
Journal of Neurotrauma
31 papers in training set
Top 0.2%
2.7%
11
Pharmacological Research
18 papers in training set
Top 0.1%
2.5%
12
Biomedicines
67 papers in training set
Top 0.5%
2.5%
13
BMC Neurology
14 papers in training set
Top 0.2%
2.2%
50% of probability mass above
14
Brain Research
38 papers in training set
Top 0.1%
2.2%
15
Scientific Reports
3612 papers in training set
Top 52%
1.8%
16
International Journal of Molecular Sciences
494 papers in training set
Top 8%
1.7%
17
EMBO Molecular Medicine
95 papers in training set
Top 1%
1.4%
18
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.4%
1.2%
19
Molecular Neurobiology
53 papers in training set
Top 0.9%
1.2%
20
Brain and Behavior
43 papers in training set
Top 1%
1.1%
21
Frontiers in Cellular Neuroscience
91 papers in training set
Top 1%
1.1%
22
Journal of Neurology
28 papers in training set
Top 0.8%
1.1%
23
British Journal of Pharmacology
40 papers in training set
Top 0.6%
1.1%
24
Heliyon
152 papers in training set
Top 7%
0.9%
25
Journal of Neuroscience Methods
122 papers in training set
Top 2%
0.9%
26
Neurotherapeutics
14 papers in training set
Top 0.3%
0.9%
27
Circulation Research
47 papers in training set
Top 1%
0.9%
28
Healthcare
17 papers in training set
Top 1.0%
0.9%
29
Frontiers in Immunology
638 papers in training set
Top 10%
0.6%
30
Neurorehabilitation and Neural Repair
21 papers in training set
Top 0.5%
0.6%